The New Health Care: The EpiPen, a Case Study in Health Care System Dysfunction

It’s a simple, lifesaving medication — yet hurdles to market entry allow a company that makes it to keep raising the price.

from NYT > Health http://ift.tt/2bfr2wQ
via health&fitness